当前位置: X-MOL 学术Nat. Biotechnol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
BTK blockers make headway in multiple sclerosis
Nature Biotechnology ( IF 46.9 ) Pub Date : 2021-01-11 , DOI: 10.1038/s41587-020-00790-7
Elie Dolgin

By targeting both arms of the immune system, not just B cells, brain-penetrant inhibitors of Bruton’s tyrosine kinase could improve on anti-CD20 therapy for patients with multiple sclerosis.

中文翻译:

BTK阻滞剂在多发性硬化症中取得进展

通过针对免疫系统的两个臂而不仅仅是B细胞,布鲁顿酪氨酸激酶的脑渗透抑制剂可以在多发性硬化症患者的抗CD20治疗中得到改善。
更新日期:2021-01-11
down
wechat
bug